🎉 M&A multiples are live!
Check it out!

NeueHealth Valuation Multiples

Discover revenue and EBITDA valuation multiples for NeueHealth and similar public comparables like Clover Health, Alignment Healthcare, and Health Italia.

NeueHealth Overview

About NeueHealth

NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.


Founded

2015

HQ

United States of America
Employees

986

Website

neuehealth.com

Financials

LTM Revenue $1.1B

LTM EBITDA $34.7M

EV

$1.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

NeueHealth Financials

NeueHealth has a last 12-month revenue of $1.1B and a last 12-month EBITDA of $34.7M.

In the most recent fiscal year, NeueHealth achieved revenue of $937M and an EBITDA of -$65.1M.

NeueHealth expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See NeueHealth valuation multiples based on analyst estimates

NeueHealth P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.2B $937M XXX XXX XXX
Gross Profit $206M $164M XXX XXX XXX
Gross Margin 18% 18% XXX XXX XXX
EBITDA -$567M -$65.1M XXX XXX XXX
EBITDA Margin -49% -7% XXX XXX XXX
Net Profit -$1.5B -$1.2B XXX XXX XXX
Net Margin -125% -123% XXX XXX XXX
Net Debt n/a $283M XXX XXX XXX

Financial data powered by Morningstar, Inc.

NeueHealth Stock Performance

As of April 15, 2025, NeueHealth's stock price is $7.

NeueHealth has current market cap of $59.4M, and EV of $1.1B.

See NeueHealth trading valuation data

NeueHealth Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.1B $59.4M XXX XXX XXX XXX $-19.40

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

NeueHealth Valuation Multiples

As of April 15, 2025, NeueHealth has market cap of $59.4M and EV of $1.1B.

NeueHealth's trades at 1.0x LTM EV/Revenue multiple, and 31.4x LTM EBITDA.

Analysts estimate NeueHealth's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for NeueHealth and 10K+ public comps

NeueHealth Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.1B XXX XXX XXX
EV/Revenue 1.2x XXX XXX XXX
EV/EBITDA -16.8x XXX XXX XXX
P/E -0.4x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -8.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get NeueHealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

NeueHealth Valuation Multiples

NeueHealth's NTM/LTM revenue growth is 32%

NeueHealth's revenue per employee for the last fiscal year averaged $0.9M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, NeueHealth's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate NeueHealth's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for NeueHealth and other 10K+ public comps

NeueHealth Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -19% XXX XXX XXX XXX
EBITDA Margin -7% XXX XXX XXX XXX
EBITDA Growth -89% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 25% XXX XXX XXX XXX
Revenue per Employee $0.9M XXX XXX XXX XXX
Opex per Employee $0.3M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 29% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 31% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

NeueHealth Public Comps

See public comps and valuation multiples for Managed Care and Health Benefits & Financial Solutions comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Genesis Fertility Center XXX XXX XXX XXX XXX XXX
Dc Healthcare Holdings XXX XXX XXX XXX XXX XXX
Health Italia XXX XXX XXX XXX XXX XXX
Alignment Healthcare XXX XXX XXX XXX XXX XXX
Clover Health XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

NeueHealth M&A and Investment Activity

NeueHealth acquired  XXX companies to date.

Last acquisition by NeueHealth was  XXXXXXXX, XXXXX XXXXX XXXXXX . NeueHealth acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by NeueHealth

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About NeueHealth

When was NeueHealth founded? NeueHealth was founded in 2015.
Where is NeueHealth headquartered? NeueHealth is headquartered in United States of America.
How many employees does NeueHealth have? As of today, NeueHealth has 986 employees.
Who is the CEO of NeueHealth? NeueHealth's CEO is Mr. G. Mike Mikan.
Is NeueHealth publicy listed? Yes, NeueHealth is a public company listed on NYS.
What is the stock symbol of NeueHealth? NeueHealth trades under NEUE ticker.
When did NeueHealth go public? NeueHealth went public in 2021.
Who are competitors of NeueHealth? Similar companies to NeueHealth include e.g. Genesis Fertility Center, Dc Healthcare Holdings, Health Italia, Alignment Healthcare.
What is the current market cap of NeueHealth? NeueHealth's current market cap is $59.4M
What is the current revenue of NeueHealth? NeueHealth's last 12-month revenue is $1.1B.
What is the current EBITDA of NeueHealth? NeueHealth's last 12-month EBITDA is $34.7M.
What is the current EV/Revenue multiple of NeueHealth? Current revenue multiple of NeueHealth is 1.0x.
What is the current EV/EBITDA multiple of NeueHealth? Current EBITDA multiple of NeueHealth is 31.4x.
What is the current revenue growth of NeueHealth? NeueHealth revenue growth between 2023 and 2024 was -19%.
Is NeueHealth profitable? Yes, NeueHealth is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.